Prescription drug savings from My Praluent

Are you struggling to afford your PRALUENT® (alirocumab) medication? Don’t worry, help is available through the MyPRALUENT® Patient Assistance Program (PAP). This program offers financial support to eligible patients who are either uninsured or have Medicare Part D coverage and meet specific income restrictions.

The benefits of MyPRALUENT® Patient Assistance Program

Copay Assistance for Commercially-Insured Patients

If you have commercial insurance, you may qualify for copay assistance through the MyPRALUENT® PAP. This means that you could pay as little as $35 per month for your PRALUENT® treatment. The copay assistance program is subject to a maximum annual amount of $3,500, and there are no income requirements to be eligible for the Copay Card. This can significantly reduce the financial burden of your medication costs.

Patient Assistance Program (PAP) for Uninsured or Medicare Part D Patients

For uninsured or Medicare Part D patients who meet income restrictions, the MyPRALUENT® PAP offers a financial solution. If you qualify, you may receive assistance with the cost of your PRALUENT® medication. The Patient Assistance Program aims to ensure that financial limitations do not hinder your access to this important treatment.

Easy enrollment process

Enrolling in the MyPRALUENT® PAP is a straightforward process. To get started, you need to provide some basic information. Select the appropriate patient assistance offering based on your insurance status. If you have commercial insurance, choose the Copay Assistance option. If you are uninsured or have Medicare Part D, select the Patient Assistance Program (PAP). Additionally, if you have already submitted an enrollment form and need to submit supporting documentation, such as proof of income or prior authorization approval/denial, you can use the Upload PAP Supporting Documentation option.

Important safety information for PRALUENT®

Before starting PRALUENT® (alirocumab), it’s crucial to discuss your medical conditions, including allergies, with your healthcare provider. Inform them if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It’s also essential to disclose all medications you are taking, including prescriptions, over-the-counter medicines, vitamins, or herbal supplements.

PRALUENT® can cause severe allergic reactions that may require treatment in a hospital. If you experience symptoms such as a severe rash, redness, hives, severe itching, trouble breathing, or swelling of the face, lips, throat, or tongue, discontinue PRALUENT® immediately and seek medical attention.

Common side effects of PRALUENT® include redness, itching, swelling, or pain/tenderness at the injection site, as well as symptoms resembling the common cold, flu, or flu-like symptoms. It’s important to notify your healthcare provider if you experience any side effects that bother you or persist.

Understanding PRALUENT® (alirocumab)

PRALUENT® (alirocumab) is an injectable prescription medicine used for the treatment of certain medical conditions. It belongs to a class of drugs called PCSK9 inhibitors, which work by reducing low-density lipoprotein cholesterol (LDL-C), also known as “bad” cholesterol levels in the blood.

Lowering LDL-C levels is essential for individuals with high cholesterol, as high LDL-C can contribute to the development of cardiovascular diseases, such as heart attacks and strokes. PRALUENT® is typically prescribed for patients who have primary hyperlipidemia or mixed dyslipidemia, conditions characterized by elevated LDL-C levels.

How does PRALUENT® work?

PRALUENT® (alirocumab) works by inhibiting an enzyme called PCSK9. This enzyme plays a crucial role in regulating the number of LDL receptors on the surface of liver cells. LDL receptors are responsible for removing LDL-C from the bloodstream. By inhibiting PCSK9, PRALUENT® increases the number of available LDL receptors, leading to increased removal of LDL-C from the blood.

The reduction in LDL-C levels achieved with PRALUENT® can help lower the risk of cardiovascular events in patients with high cholesterol. It is important to note that PRALUENT® should be used in conjunction with a healthy lifestyle, including a proper diet and exercise, to achieve optimal results.

How to use PRALUENT®

To administer PRALUENT®, it is crucial to follow the instructions provided by your healthcare provider. PRALUENT® is an injectable medication that is self-administered subcutaneously (under the skin). Your healthcare provider will guide you on the correct technique for preparing and giving yourself a PRALUENT® injection. It is essential to carefully read and understand the “Instructions For Use” that come with PRALUENT® to ensure proper administration.

Conclusion

The MyPRALUENT® Patient Assistance Program (PAP) provides a lifeline for patients who struggle to afford their PRALUENT® medication. Whether you have commercial insurance or are uninsured with Medicare Part D coverage, the program offers copay assistance and financial support to ensure that you can access this vital treatment.

Remember to consult your healthcare provider for personalized advice before starting PRALUENT®. Follow the instructions provided for proper PRALUENT® administration. By taking advantage of the MyPRALUENT® PAP, you can focus on managing your health without the added stress of financial burdens. Enroll today and take a step towards a healthier future.

Sources

• Starting and Paying for PRALUENT – PRALUENT® (alirocumab) Injection